Cure My Disease

Don't miss your cure!

 Log in / Sign up

Friendship groups boost HIV care and cut problem drinking

NCT ID NCT03157258

Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether bringing together groups of friends who all have HIV helps them support each other to stay in medical care and take their medications. Over 300 people in St. Petersburg, Russia, took part. The approach uses everyday friendships to encourage regular doctor visits and reduce heavy drinking, rather than relying on individual counseling alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

341 people

The number who actually took part.

Started

Jun 2017

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 or older; * Self-report as being HIV-positive, with positive HIV status confirmed in study-provided testing; * Except for initial seeds, must be named by an already-enrolled participant as a PLH friend; and * Do not plan to move from the St. Petersburg, Russia, area for the next 18 months. Exclusion Criteria: * Age 17 or younger; * Self-report as HIV-negative or HIV-positive serostatus is not confirmed by testing; * Not be named as a PLH friend by an already-enrolled participant; and * Intend to move from the St. Petersburg, Russia, area during the next 18 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS Human immunodeficiency virus

Contacts and locations

Locations

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.